Retrospective Study
Copyright ©The Author(s) 2017.
World J Clin Oncol. Aug 10, 2017; 8(4): 343-350
Published online Aug 10, 2017. doi: 10.5306/wjco.v8.i4.343
Figure 1
Figure 1 Kaplan-Meier survival curves. Survival time for BC vs CRC (P = 0.042, χ2 test). 1: Survival data of all patients with liver metastases of BC after TACP (n = 19). Median survival time 13.2 mo; 2: Survival data of patients with liver metastases of CRC after TACP (n = 17). Median survival time 9.3 mo. BC: Breast cancer; CRC: Colorectal cancer; TACP: Trans-arterial chemoperfusion.